Document is current
Any future updates will be listed below
-
Authors
Freeman, Jincong Q. https://orcid.org/0000-0002-1119-2146
Sheade, Jori B. https://orcid.org/0000-0002-1283-8308
Zhao, Fangyuan https://orcid.org/0000-0001-9776-3677
Olopade, Olufunmilayo I. https://orcid.org/0000-0002-9936-1599
Huo, Dezheng https://orcid.org/0000-0002-4041-1678
Nanda, Rita https://orcid.org/0000-0001-5248-0876
-
Funding
Funding for this research was provided by:
Susan G. Komen (TREND21675016, TREND21675016)
National Institute on Aging (T32AG000243)
Iannessa family (donation, donation)
National Cancer Institute (P20CA233307, P20CA233307, P20CA233307)
Breast Cancer Research Foundation (BCRF-23-071, BCRF-23-071, BCRF-23-071)
- License Information
-
More Information
Article History
Received: 29 January 2024
Accepted: 24 April 2024
First Online: 15 May 2024
Declarations
:
: J.Q.F., J.B.S., F.Z., and D.H. have no relevant financial or non-financial conflict of interests to disclose. R.N. disclosed advisory board involvement with and research funding from Arvinas, AstraZeneca, BeyondSpring, Celgene, FujiFilm, Genentech/Roche, Gilead, Infinity, iTeos, Merck, OBI Pharma, OncoSec, Pfizer, Relay Therapeutics, SeaGen, Sun Pharma, and Taiho. O.I.O. disclosed financial relationships with CancerIQ, 54gnene, HealthWell Solutions, Tempus; research funding from Ayala Pharmaceuticals, Cepheid, Color Genomics, Novartis, and Roche/Genentech.
: This study was conducted in line with the principles of the Declaration of Helsinki. Ethnics approval was granted by the University of Chicago Institutional Review Board.
: Written informed consent was obtained from all patients prior to study enrollment and participation.
: Not applicable.
